Literature DB >> 26166554

MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.

Sung Lyea Park1, Tae-Min Cho2, Se Yeon Won1, Jun-Hui Song1, Dae-Hwa Noh1, Wun-Jae Kim3, Sung-Kwon Moon1.   

Abstract

MicroRNAs (miRs) serve either as oncogenes or tumor-suppressor genes in tumor progression. MicroRNA-20b (miR‑20b) is known to be involved with the oncomirs of several types of cancers. However, in the present study we describe how miR-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells. In the present study, miR-20b was downregulated in bladder cancer cell lines, and its overexpression resulted in a significant reduction in the proliferation of EJ cells. In addition, via a bioinformatics approach, we identified cell cycle-regulated genes that are the putative targets of miR-20b. The transfection of miR-20b into EJ cells induced G1 phase cell cycle arrest via the decreased expression of cyclin D1, CDK2 and CDK6 without affecting another G1 phase cell cycle regulator, cyclin E. The cell cycle inhibitor p21WAF1 was upregulated in the miR-20b transfected cells. Moreover, the enforced expression of miR-20b resulted in impaired wound-healing migration and invasion in the EJ cells. Based on our target prediction analysis of miRs, we confirmed that miR-20b overexpression strongly impedes MMP-2 expression via suppressive activation of the Sp-1 binding motif, an important transcription factor present in the MMP-2 promoter. Herein, we report the novel concept that miR-20b exerts a suppressive effect on both cell cycle-modulated proliferation and MMP-2-mediated migration and invasion in bladder cancer EJ cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26166554     DOI: 10.3892/or.2015.4119

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  14 in total

1.  Indirect Down-regulation of Tumor-suppressive let-7 Family MicroRNAs by LMO1 in Neuroblastoma.

Authors:  Norihisa Saeki; Akira Saito; Yuki Sugaya; Mitsuhiro Amemiya; Hiroki Sasaki
Journal:  Cancer Genomics Proteomics       Date:  2018 Sep-Oct       Impact factor: 4.069

2.  Prognostic value of microRNA-20b expression level in patients with prostate cancer.

Authors:  Rongkui Zhang; Fuwei Li; Yuchong Wang; Ming Yao; Changliang Chi
Journal:  Histol Histopathol       Date:  2020-04-14       Impact factor: 2.303

3.  Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.

Authors:  Xiang Ao; Peipei Nie; Baoyan Wu; Wei Xu; Tao Zhang; Songmao Wang; Haocai Chang; Zhengzhi Zou
Journal:  Cell Death Dis       Date:  2016-11-10       Impact factor: 8.469

4.  ISO, via Upregulating MiR-137 Transcription, Inhibits GSK3β-HSP70-MMP-2 Axis, Resulting in Attenuating Urothelial Cancer Invasion.

Authors:  Xirui Guo; Haishan Huang; Honglei Jin; Jiheng Xu; Sanjiv Risal; Jingxia Li; Xin Li; Huiying Yan; Xingruo Zeng; Lei Xue; Changyan Chen; Chuanshu Huang
Journal:  Mol Ther Nucleic Acids       Date:  2018-07-04       Impact factor: 8.886

5.  Long non-coding RNA cardiac hypertrophy-associated regulator governs cardiac hypertrophy via regulating miR-20b and the downstream PTEN/AKT pathway.

Authors:  Mingyu Zhang; Yuan Jiang; Xiaofei Guo; Bowen Zhang; Jiangjiao Wu; Jiabin Sun; Haihai Liang; Hongli Shan; Yong Zhang; Jiaqi Liu; Ying Wang; Lu Wang; Rong Zhang; Baofeng Yang; Chaoqian Xu
Journal:  J Cell Mol Med       Date:  2019-08-29       Impact factor: 5.310

6.  miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.

Authors:  Hui Yang; Jian Lin; Jinling Jiang; Jun Ji; Chao Wang; Jun Zhang
Journal:  Cell Cycle       Date:  2020-10-12       Impact factor: 4.534

7.  Enhancing the sensitivity of ovarian cancer cells to olaparib via microRNA-20b-mediated cyclin D1 targeting.

Authors:  Qian Zhong; Ying Xiong; Chen Ling; Yanping Qian; Xia Zhao; Hanshuo Yang
Journal:  Exp Biol Med (Maywood)       Date:  2021-06

8.  A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.

Authors:  Xin Zhou; Wei Wen; Jun Zhu; Zebo Huang; Lan Zhang; Huo Zhang; Lian-Wen Qi; Xia Shan; Tongshan Wang; Wenfang Cheng; Danxia Zhu; Yin Yin; Yan Chen; Wei Zhu; Yongqian Shu; Ping Liu
Journal:  Oncotarget       Date:  2017-05-23

9.  PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.

Authors:  Minggang Peng; Jingjing Wang; Dongyun Zhang; Honglei Jin; Jingxia Li; Xue-Ru Wu; Chuanshu Huang
Journal:  Oncogene       Date:  2018-06-21       Impact factor: 9.867

Review 10.  miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer.

Authors:  Zhonglin Cai; Fa Zhang; Weijie Chen; Jianzhong Zhang; Hongjun Li
Journal:  Onco Targets Ther       Date:  2019-12-31       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.